Tianchen Biotechnology-B(01779): Hong Kong public offering oversubscribed by 4762.58 times, with net proceeds of approximately HK$1.255 billion raised globally.
Tencent Biological-B (01779) announced the distribution results, the company sold a total of 14.19315 million shares globally, with 10% sold in Hong Kong and 90% sold internationally. The final offer price was HK$96.06 per share, raising approximately HK$1.255 billion through the global sale. Trading of H shares, with each lot consisting of 50 shares, is expected to begin on the Hong Kong Stock Exchange at 9am on June 5, 2026 (Friday).
Tianchen Biopharma-B (01779) announced the results of the placement, with a global offering of 14.19315 million shares, of which 10% were sold publicly in Hong Kong and 90% were sold internationally. The final offering price was HK$96.06 per share, raising approximately HK$1.255 billion. Trading of H shares is expected to begin on Friday, June 5, 2026 at 9:00 am (Hong Kong time), with each board lot consisting of 50 shares.
The Hong Kong public offering was oversubscribed by 4,762.58 times, while the international offering was oversubscribed by 10.94 times.
Related Articles
US Stock Market Move | Cross-border securities business rectification collectively landed, UP Fintech Holding Ltd. Sponsored ADR Class A (TIGR.US) increased by over 2% in early trading.
"Wood Sister" Wood aggressively increased their holdings in Alphabet Inc. Class C, a subsidiary of Alphabet Inc. (GOOGL.US), with a total purchase of over 260,000 shares across four funds.
US Stock Market Move | Increasing investment in the layout of pharmaceutical production capacity in the United States, Eli Lilly (LLY.US) surged over 5% in early trading.
US Stock Market Move | Cross-border securities business rectification collectively landed, UP Fintech Holding Ltd. Sponsored ADR Class A (TIGR.US) increased by over 2% in early trading.
"Wood Sister" Wood aggressively increased their holdings in Alphabet Inc. Class C, a subsidiary of Alphabet Inc. (GOOGL.US), with a total purchase of over 260,000 shares across four funds.
US Stock Market Move | Increasing investment in the layout of pharmaceutical production capacity in the United States, Eli Lilly (LLY.US) surged over 5% in early trading.
